ATPC vs AZN · P/E 6.1, rev $382.8K vs P/E 28, $288.38B cap
Agape ATP Corporation Common Stock (ATPC) versus AstraZeneca PLC (AZN) — a side-by-side from cached financials, not a winner call.
Agape ATP Corporation Common Stock (ATPC) is a packaged foods company listed on NASDAQ.
AstraZeneca PLC (AZN) is a drug manufacturers - general company listed on US.
Latest reported ATPC revenue for 2026-06-30 was $382.8K. Net income was -$191.5K. Revenue was up 39.9% from 2026-03-31 to 2026-06-30. ATPC currently screens at market cap $2.7M and trailing P/E 6.1.
AZN does not have a complete income-statement cache yet.
ATPC currently screens at market cap $2.7M and trailing P/E 6.1. AZN currently screens at market cap $288.38B and trailing P/E 28.0.
Not investment advice. Open the ATPC and AZN stock pages for the full models.
Not investment advice.